Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia
Background: Remdesivir is the only antiviral treatment that has been shown to be useful against SARS-CoV-2 infection. It shorts hospitalization time compared to placebo. Its effects in Kidney transplant (KT) patients are limited to some published cases. Methods: We performed a retrospective observat...
Main Authors: | Judit Cacho, Elena Burgos, María Molina, Andrés Villegas, Mónica Pérez, Laura Cañas, Omar Taco, Javier Juega, Ricardo Lauzurica |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-05-01
|
Series: | Nefrología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251422000840 |
Similar Items
-
Remdesivir en pacientes trasplantados renales con neumonía por SARS-CoV-2
by: Judit Cacho, et al.
Published: (2022-05-01) -
Kidney transplant survival in relation to immunological compatibility in Cuba
by: Alexander Mármol Sóñora, et al.
Published: (2022-02-01) -
Acute kidney failure in patients admitted due to COVID-19
by: Blanca Tarragón, et al.
Published: (2021-01-01) -
Revisión y análisis de los resultados de los programas de trasplante renal en México
by: Marco A. Ayala-García, et al.
Published: (2024-01-01) -
Supervivencia del injerto y del receptor en el trasplante renal en el hospital Guillermo Gran Benavente (Concepción, Chile)
by: Magali Rodríguez Vidal, et al.
Published: (2014-12-01)